Clinical Bioanalysis

Veeda Biopharma offers comprehensive large-molecule bioanalytical services for both early and late-phase clinical trials. We deliver precise data using advanced technology and strict quality assurance, adhering to GCP and GLP standards. Our expertise ensures accurate, efficient analysis, empowering informed decisions for successful biotherapeutic development.

A close-up of a scientist's gloved hands holding a microplate and test tubes, representing Veeda's clinical bioanalysis lab services.

PK/PD and Immunogenicity Testing with Advanced Bioanalytical Platforms

Veeda Biopharma offers clinical bioanalysis services for method development, validation, and sample analysis using state-of-the-art LC-MS/MS and Ligand Binding Assay platforms (ELISA and ECL) for bioanalysis of biotherapeutics, meeting the needs of clients involved in drug development and regulatory submissions utilizing robust, sensitive, specific and reproducible methods.

Icon 1

Quantify Free/Bound/Total
Drug Concentrations in Biological Matrices

Icon 2

Analysis of Anti-Drug Antibodies (ADAs)
Using Tier-Based Approach
line

Screening

Confirmatory

Titer

Antibody Icon

Neutralizing Antibody (NAb)
Detection – Cell-Based or
Competitive Ligand Binding (CLB) Assays

Icon 4

Biomarker
Estimations

Accelerate Your Vaccine Program with Reliable &
High-Quality Immunogenicity Testing

A rotating 3D model of an antibody or protein molecule, representing the advanced immunogenicity testing for vaccine programs.

Veeda Biopharma accelerates vaccine development with rapid, high-quality immunogenicity testing for bacterial and viral vaccines. Our innovative immuno-analytical methods ensure precise results, focusing on humoral and cell-mediated immune responses, helping you achieve the highest scientific standards for your vaccine programs.

Assay List

Veeda Lifesciences offers a comprehensive suite of bioanalytical assays for Generics, New Chemical Entities (NCEs), Biotherapeutics. Our services include custom assay development, validation and sample analysis for small molecules and large molecules, with focus on pharmacokinetics (PK), pharmacodynamics (PD), immunogenicity testing and biomarker analysis. Leveraging advanced ligand-binding platforms and mass spectrometry technologies, we ensure high-quality and precise results. Our assays support all stages of drug development, including biosimilar development, ensuring regulatory compliance and the highest scientific standards.

Know More

Maximizing Assay Accuracy and Consistency through Advanced Critical Reagent Development

We offer specialized critical reagent development services to ensure the accuracy and consistency of your Ligand Binding Assays. By leveraging advanced characterization techniques, we optimize reagents for specificity, affinity, stability, and purity, enabling precise and reproducible measurements of target analytes in biological samples.

Generation

Purification

Labelling of Critical Reagents

Qualification

Clinical bioanalysis expert using a tablet with advanced technology icons, representing precision healthcare

Achieving Regulatory Excellence Through Global Quality Standards and GCLP Compliance

Clinical Bioanalysis team utilizes a robust Quality Management System (QMS) to ensure the highest quality data at every stage of analysis, providing the accountability and traceability necessary for regulatory submissions. Our bioanalytical services are conducted in GCLP-compliant laboratories, adhering to stringent regulatory guidelines from ICH, FDA, EMA, and current industry whitepapers.

State-of-the-Art Technologies

The AB SCIEX QTRAP 6500+ Mass Spectrometer, a key piece of advanced equipment used for clinical bioanalysis.

AB SCIEX QTRAP 6500+

The BioTek Synergy H1 multimode microplate reader, a key piece of equipment used for clinical bioanalysis.

BioTek Synergy H1

The MSD QuickPlex SQ 120, a high-sensitivity multiplex immunoassay system used for advanced clinical bioanalysis.

MSD QuickPlex SQ 120